APS Announces New Co-Leader for the Biopharmaceutics Focus Group 14 November 2024 After chairing the Biopharmaceutics Focus Group for a few years, Nikoletta Fotaki has decided to stand down. The APS are pleased to announce that Chris Roe will now be the Co-Leader of the Biopharmaceutics Focus Group alongside Chara Litou. Chris Roe Senior Research Fellow, Scientific Consulting, Quotient Sciences “I’m delighted to be joining Chara in leading the APS Biopharmaceutics Focus Group and honored to be following Nikoletta in this role which she has done brilliantly over the last few years. I’m looking forward to continuing the great work of the group in promoting scientific education, training and cross-sector pre-competitive collaboration within the field of biopharmaceutics through the group’s development and delivery of webinars, [...]

Dr Bahijja Raimi-Abraham Steps Down from the APS Board 1st November 2024 Dr Bahijja Raimi-Abraham has decided to step down from the APS Board. "I have decided to step down from my role on the APS Board to embark on a 12-month secondment at the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria, made possible by The Academy of Medical Sciences Cross Sector Experience Award. I have truly enjoyed and valued my time as an APS Board Member, and I am deeply grateful for the support I’ve received throughout my tenure. I wish the Board and APS continued success in the future and look forward to seeing the ongoing impact of their important work [...]

APS Board Members - Call for Applications 22nd October 2024 Following the retirement of two APS Board Members, the APS is now seeking applications from individuals interested in becoming Board Members. We are particularly interested in applications from those working in pharmaceutical industry and academics working at APS Accredited Universities. The APS Board currently consists of 10 members https://apsgb.co.uk/about-us/ who are registered as Directors of APS at Companies House. This means that becoming a member of the Board brings legal obligations related to the management of APS. Board members are expected to attend at least 4 APS full Board meetings per year (currently approximately every 2 months by Zoom, for 2-3 hours), and regular Board meetings every other week for an hour [...]

The APS is delighted to announce that the new APS Chair for 2024 and 2025 will be Professor Ryan Donnelly. Professor Ryan Donnelly holds the Chair in Pharmaceutical Technology at Queen’s University Belfast....

After three years chairing the Emerging Technologies Focus Group, Dimitrios Lamprou has decided to stand down.  The APS are pleased to announce that Dr Atheer Awad will now be the Emerging Technologies Focus Group Lead.

The APS is delighted to announce that the new APS Chair for 2024 and 2025 will be Professor Ryan Donnelly. Professor Ryan Donnelly holds the Chair in Pharmaceutical Technology at Queen’s University Belfast....

Your continued feedback is welcome. Jo Craig as the PharmSci 2023 Conference Chair and Hannah Batchelor as the current APS Chair were delighted with the APS PharmSci 2023 Conference in Reading from 5-7th September 2023.